Pharmacology of nadolol (SQ 11725), a β-adrenergic antagonist lacking direct myocardial depression

This publication has 16 references indexed in Scilit:

• The Myocardial Depressant Effect of Beta-Receptor Blocking Agents
  Circulation Research, 1974
• ??-Adrenergic Receptor Blocking Drugs in Angina Pectoris
  Drugs, 1974
• Beta adrenergic blockade in hypertension: Practical and theoretical implications of long-term hemodynamic variations
  The American Journal of Cardiology, 1972
• Assessment of propranolol in angina pectoris. Clinical dose response curve and effect on electrocardiogram at rest and on exercise.
  Heart, 1971
• Pharmacological Testing Methods for Drugs Acting on the Peripheral Nervous System
  Journal of Pharmaceutical Sciences, 1970
• FREE NORADRENALINE AND ADRENALINE EXCRETION IN RELATION TO THE DEVELOPMENT OF CARDIAC ARRHYTHMIAS AND HEART-FAILURE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1969
• EVALUATION OF THE CARDIAC EFFECTS OF SEVERAL BETA ADRENERGIC BLOCKING AGENTS
  Annals of the New York Academy of Sciences, 1967
• Metabolism of Propranolol (‘Inderal’), a Potent, Specific β-Adrenergic Receptor Blocking Agent
  Nature, 1967
• Propranolol in hypertension
  The American Journal of Cardiology, 1966
• A NEW ADRENERGIC: BETA-RECEPTOR ANTAGONIST
  Published by Elsevier ,1964